An NPR story regarding Pfizer's decision to settle with Brigham Young University over the creation of prescription pain reliever Celebrex featured commentary from Andrew Torrance, professor of law.
Andrew Torrance's recent publication on synthetic biology received positive press in an online Forbes article.
Synthetic biology is only just emerging into public awareness. As it progresses, the field will present several dilemmas to both public opinion and existing legal and regulatory regimes. Two recent publications do much to introduce synthetic biology to the general public: “A synthetic biology roadmap for the UK,” from Research Councils UK; and “Planted Obsolescence: Synagriculture and the Law,” by Andrew Torrance, in the Idaho Law Review.